Press Releases
Novartis, AMSP collaborate to facilitate supply of COVID-19 related medicines to AU member states & Caricom countries
Novartis and the African Union (AU) through the Africa Medical Supplies Platform (AMSP) have announced a new collaboration to facilitate the supply of medicines from the Novartis Pandemic Response Portfolio to the AU member states and Caricom countries.
The AMSP...
Press Releases
Sinovac Signs Agreement with Bio Farma Indonesia for COVID-19 Vaccine Cooperation
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced it has signed two agreements in Hainan, China with PT Bio Farma, a leading biopharmaceutical company in Indonesia, for the supply, local production and technology licensing in...
Press Releases
Biocon Biologics and Mylan Announce Launch of Semglee in the U.S. to Expand Access for Patients Living with Diabetes
Biocon Biologics India Ltd., a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd., and Mylan N.V. announced the U.S. launch of Semglee™ (insulin glargine injection) in vial and pre-filled pen presentations, approved to help control...
Press Releases
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
Gilead Sciences, Inc. announced an agreement with Jounce Therapeutics, Inc., a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, to exclusively license its JTX-1811 program.
JTX-1811 is a monoclonal antibody designed to selectively...
Press Releases
Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs
Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, announced the closing of a $16 million Series B financing. The financing was co-led by new investor WestRiver Management and returning investor Bioeconomy Capital, with additional...
Press Releases
Avacta Expands Rapid SARS-CoV-2 Antigen Test Manufacturing Capacity
Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into an agreement with Abingdon Health for the manufacture of Avacta’s saliva-based rapid SARS-CoV-2 antigen test as part of its ongoing...
Press Releases
Promega Launches Spectrum Compact CE Benchtop DNA Analysis Instrument with Hitachi High-Tech
Promega launched its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System, developed in collaboration with Hitachi High-Tech. The personal CE system is an integrated DNA analysis instrument that enables life scientists in laboratories of all sizes to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















